GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » EV-to-EBITDA

Genflow Biosciences (LSE:GENF) EV-to-EBITDA

: -3.38 (As of Today)
View and export this data going back to 2022. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Genflow Biosciences's enterprise value is £4.00 Mil. Genflow Biosciences's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was £-1.18 Mil. Therefore, Genflow Biosciences's EV-to-EBITDA for today is -3.38.

The historical rank and industry rank for Genflow Biosciences's EV-to-EBITDA or its related term are showing as below:

LSE:GENF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -19.51   Med: 0   Max: 0
Current: -3.38

LSE:GENF's EV-to-EBITDA is ranked worse than
100% of 469 companies
in the Biotechnology industry
Industry Median: 9.16 vs LSE:GENF: -3.38

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-19), Genflow Biosciences's stock price is £0.01575. Genflow Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.004. Therefore, Genflow Biosciences's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Genflow Biosciences EV-to-EBITDA Historical Data

The historical data trend for Genflow Biosciences's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Annual Data
Trend Dec21 Dec22
EV-to-EBITDA
- -2.62

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBITDA - - - - -

Competitive Comparison

For the Biotechnology subindustry, Genflow Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genflow Biosciences EV-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's EV-to-EBITDA falls into.



Genflow Biosciences EV-to-EBITDA Calculation

Genflow Biosciences's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4.000/-1.182
=-3.38

Genflow Biosciences's current Enterprise Value is £4.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genflow Biosciences's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was £-1.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genflow Biosciences  (LSE:GENF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Genflow Biosciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.01575/-0.004
=At Loss

Genflow Biosciences's share price for today is £0.01575.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genflow Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Genflow Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences (LSE:GENF) Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences (LSE:GENF) Headlines

No Headlines